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ABSTRACT Interactions of cationic antimicrobial peptides with living bacterial and mammalian cells are little understood,
although model membranes have been used extensively to elucidate how peptides permeabilize membranes. In this study, the
interaction of F5W-magainin 2 (GIGKWLHSAKKFGKAFVGEIMNS), an equipotent analogue of magainin 2 isolated from the
African clawed frog Xenopus laevis, with unﬁxed Bacillus megaterium and Chinese hamster ovary (CHO)-K1 cells was
investigated, using confocal laser scanning microscopy. A small amount of tetramethylrhodamine-labeled F5W-magainin 2 was
incorporated into the unlabeled peptide for imaging. The inﬂux of ﬂuorescentmarkers of various sizes into the cytosol revealed that
magainin 2 permeabilized bacterial and mammalian membranes in signiﬁcantly different ways. The peptide formed pores with a
diameter of;2.8 nm (, 6.6 nm) inB.megaterium, and translocated into the cytosol. In contrast, the peptide signiﬁcantly perturbed
the membrane of CHO-K1 cells, permitting the entry of a large molecule (diameter, .23 nm) into the cytosol, accompanied by
membrane budding and lipid ﬂip-ﬂop, mainly accumulating in mitochondria and nuclei. Adenosine triphosphate and negatively
charged glycosaminoglycans were little involved in the magainin-induced permeabilization of membranes in CHO-K1 cells.
Furthermore, the susceptibility of CHO-K1 cells to magainin was found to be similar to that of erythrocytes. Thus, the distinct
membrane-permeabilizing processesofmagainin 2 in bacterial andmammalian cellswere, to thebest of our knowledge, visualized
and characterized in detail for the ﬁrst time.
INTRODUCTION
Antimicrobial peptides (AMPs) are short cationic peptides
with an amphiphilic nature. They play an important role in the
innate immunity of host organisms, including animals, plants,
and humans (1). The AMPs are promising candidates for
novel anti-infective drugs (2) because they are effective against
antibiotic-resistant bacteria. Because early studies suggested
that many AMPs target membranes (3–5), the molecular
mechanism of membrane permeabilization has been studied
extensively, using mainly model membranes. For example,
magainin2 (GIGKFLHSAKKFGKAFVGEIMNS), ana-helical
peptide isolated from the African clawed frog Xenopus
laevis (6), was suggested to form a toroidal pore with a di-
ameter of 2–3 nm, inducing lipid ﬂip-ﬂop and the transloca-
tion of peptides into the inner leaﬂet of the bilayer coupled to
membrane permeabilization (7,8). However, the interactions
of AMPs with bacterial membranes are not well-character-
ized. For instance, membrane potential assays using bacterial
cells reveal the kinetics of the permeabilization, but do not
give information on pore size, which is essential for dis-
criminating between various proposed models of membrane
permeabilization. Electronmicroscopic observations failed to
capture the dynamic process of membrane permeabilization.
Regarding interactions of AMPs with mammalian cell
membranes, there have been only a few reports (9–12). It is
not unreasonable that most research on AMPs has focused on
their antibacterial mechanism. However, the cytotoxic effects
of AMPs also need to be studied, because they hamper the
systemic application of AMPs (2).
We investigated the interaction of F5W-magainin 2 (MG),
an equipotent analogue of magainin 2 (13), with membranes
of living bacteria and mammalian cells, using confocal laser
scanning microscopy (CLSM). The peptide was doped with a
small amount of tetramethylrhodamine-labeledMG(TAMRA-
MG) for imaging.
Bacillus megaterium and Chinese hamster ovary (CHO)-
K1 cells were selected as bacterial and mammalian cells, re-
spectively. All cells used in this studywere unﬁxed and living,
because the ﬁxation process may signiﬁcantly alter the in-
tracellular distribution of cationic peptides (14). Most pre-
vious studies used ﬁxed cells, regardless of whether they
were bacterial or mammalian (9–12,15–17).
The inﬂux of soluble ﬂuorescent molecules of various
sizes into the cytosol was monitored, to estimate the size of
pores formed by MG. In mammalian cells, the effects of the
depletion of ATP and the negatively charged glycosamino-
glycans (GAGs) on the membrane-permeabilizing activity of
MG were also examined. Fluorescein isothiocyanate (FITC)-
labeled annexin V (AV), which speciﬁcally recognizes
phosphatidylserine (PS) (18), was used to detect the lipid ﬂip-
ﬂop induced by MG. We found that MG permeabilized both
bacterial and mammalian membranes. However, the mode of
action differed signiﬁcantly between the two. The peptide formed
pores with a diameter of ;2.8 nm (,6.6 nm) in the mem-
branes of B. megaterium, and was translocated into the cy-
tosol. In contrast, the peptide signiﬁcantly perturbed the
plasma membrane of CHO-K1 cells, permitting the entry of a
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large molecule (diameter, .23 nm) into the cytosol, ac-
companied by membrane budding and lipid ﬂip-ﬂop, mainly
accumulating in the mitochondria and nuclei. Themembrane-
permeabilizing activity of MG was not inﬂuenced by ATP
and GAGs. Furthermore, the susceptibility of CHO-K1 cells to
magainin was found to be similar to that of erythrocytes. This
study visualized and characterized in detail the distinct mem-
brane-permeabilizing processes of MG in bacterial and mam-
malian cells for the ﬁrst time, to the best of our knowledge.
MATERIALS AND METHODS
Materials
An a-modiﬁcation of Eagle’s mediumwas purchased from ICNBiomedicals
(Aurora, OH). The FITC-conjugated AV, TAMRA succinimidyl ester, and
Alexa Fluor 647 monoclonal antibody labeling kit were purchased from
Invitrogen (Carlsbad, CA). Carbonic anhydrase (CA) and 2-deoxyglucose
(DG) were obtained from MP Biomedicals (Irvine, CA) and Wako Pure
Chemicals (Osaka, Japan), respectively. Calcein and 39,69-di(O-acetyl)-49,
59-bis [N,N-bis(carboxymethyl)aminomethyl] ﬂuorescein, tetraacetoxymethyl
ester (calcein-AM) were purchased from Dojindo Laboratories (Kumamoto,
Japan). The 4-kDa FITC-dextran, 20-kDa FITC-dextran, Mitotracker Green
FM, and antimycin A were obtained from Sigma (St. Louis, MO). All other
chemicals were obtained from Nacalai Tesque (Kyoto, Japan). The synthesis
of MG and labeling of N-terminal free peptides with TAMRA were per-
formed according to a standard 9-ﬂuorenylmethoxycarbonyl-based solid-
phase method (single peak by high-performance liquid chromatography).
The CA was labeled using an Alexa Fluor 647 labeling kit, according to the
manufacturer’s instructions.
Cell culture
B.megateriumNBRC13498 cells were cultured in 200mLofmedium (10 g/L
polypepton, 2 g/L yeast extract, and 1 g/L MGSO4  7H2O) at 30C. After a
20-h incubation, the culture was collected by centrifugation (4C, 3000 rpm,
10 min), and washed once with buffer (5 mM HEPES, 100 mM KCl, and 20
mM glucose, pH 7.4). The cells (OD600 ¼ 0.2) were then cultured onto a
poly-D-lysine-coated, glass-bottomed 35-mm dish.
The CHO-K1 cells, CHO pgsA-745 lacking GAGs, and pgsD-677 lacking
heparan sulfate were cultured in the a-modiﬁcation of Eagle’s medium
containing 10% fetal bovine serum, 100 units/mL penicillin, and 0.1 mg/mL
streptomycin at 37Cwith 5%CO2. After being plated onto a glass-bottomed
35-mmdish (100,000 cells) for CLSM and onto a 96-well microplate (10,000
cells) for the calcein-leakage assay, cells were incubated for 20 h at 37C
with 5% CO2. The medium was removed, and cells were resuspended with
annexin-binding buffer (10 mMHEPES, 140 mMNaCl, and 2.5 mMCaCl2,
pH 7.4) for CLSM, and phosphate-buffered saline (PBS) (8.00 g/L NaCl,
0.20 g/L KCl, 1.15 g/L Na2HPO4, and 0.2 g/L KH2PO4, pH 7.4) for the
calcein-leakage assay.
Visualization of membrane permeabilization
Soluble ﬂuorescent molecules (calcein, 4.4 kDa FITC-dextran, or 20 kDa
FITC-dextran, 40 kDa FITC-dextran, 70 kDa FITC-dextran, and 250 kDa
FITC-dextran) were added to B. megaterium or CHO-K1 cells in a glass-
bottomed dish at ﬁnal concentrations of 2 mM, 0.16 mg/mL, 0.32 mg/mL,
0.16 mg/mL, 0.16 mg/mL, and 0.16 mg/mL, respectively. Small aliquots of
peptides (8.7 mL) were added directly into the dish at a ﬁnal concentration of
10 mM (9.8 mM MG and 0.2 mM TAMRA-MG). No cell that permitted the
inﬂux of ﬂuorescent molecules was found among cells to which TAMRA-
MG did not bind, and TAMRA-MG alone (0.2 mM) did not induce signiﬁ-
cant binding or permeabilization, indicating that TAMRA-MG andMG have
similar membrane-permeabilizing activity. Indeed, TAMRA-MG exhibited
membrane-permeabilizing activity comparable to that of the parent peptide
(Supplementary Material, Data S1). Confocal images were taken using a Zeiss
LSM510 (Oberkochen, Germany) or a Nikon C1 (Tokyo, Japan) confocal laser
scanning microscope. The percentage of inﬂux was calculated from ﬂuorescent
intensity (FI), according to the following equation, by examining 20–60 cells:
The FI at 3 and 5 min after the addition of peptide solution was chosen for bac-
terial and themammalian cells, respectively, becauseFI almost reached a plateau.
Colocalization of MG and mitochondria-speciﬁc
marker in CHO-K1 cells
After being plated onto a glass-bottomed 35-mm dish (100,000 cells) for
CLSM, cells were incubated for 20 h at 37Cwith 5%CO2. The mediumwas
removed, and cells were resuspended with PBS (0.1% dimethylsulfoxide)
containing 80 nMMitotracker Green FM. After a 30-min incubation with 5%
CO2, small aliquots of peptides (10 mL) were added directly into the dish at a
ﬁnal concentration of 10 mM (9.8 mMMG and 0.2 mM TAMRA-MG), and
observed using CLSM.
Calcein-leakage assay
After cells in a 96-well microplate were washed three times with PBS, re-
suspended with 2 mM calcein-AM in PBS (0.2% dimethylsulfoxide) or ve-
hicle, and incubated for 1 h to allow calcein-AM to produce ﬂuorescent
calcein in the cytosol, free calcein-AM and calcein were removed bywashing
with PBS. The peptide solution (10mMMG in PBS) or PBSwas added to the
cells, followed by incubation for 1 h. Each well was washed three times, and
cells were resuspended with 120 mL of PBS/Triton-X (5:1, v/v). Aliquots
(100mL) of the sample were taken into a quartz cell containing 2 mL of PBS.
Fluorescence intensity was measured on a Shimadzu RF-5300 spectroﬂuo-
rometer (Kyoto, Japan) at an excitationwavelength of 490 nm and at an emission
wavelength of 515 nm. The percentage of calcein content was calculated as
% calcein content ¼ ðFIcp  FIvbÞ=ðFIcb  FIvbÞ;
where subscripts c and v refer to calcein-AM-treated and vehicle-treated
cells, respectively. Subscripts p and b denote peptide-treated and buffer-
treated cells, respectively. Antimycin A (50 nM) and DG (50 mM) were used
for ATP depletion (19). Calcein-loaded cells were incubated with the
reagents for 30 min before the addition of peptide solution containing the
same amount of inhibitors.
% influx ¼ ðFI in cell with fluorescent molecule influx FI in cells without fluorescent molecule influxÞ=
ðFI out of cell FI in cells without fluorescent molecule influxÞ3 100:
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Lipid ﬂip-ﬂop in CHO cells
Small aliquots of peptides (8.7 mL) were added directly into the dish at a
ﬁnal concentration of 10mM(9.8mMMGand 0.2mMTAMRA-MG).After a
15-min incubation, cells were washed three times with the annexin-binding
buffer to close pores, and prevent AV from recognizing PS in the inner leaﬂet
of the cell membrane. Cells were resuspended in 1 mL of annexin-binding
buffer containingAlexa647-labeledCA (the concentrationwas adjusted at 0.6
mMof Alexa Fluor 647) and 50 mL of FITC-AV, and observed using CLSM.
Hemolysis
Human erythrocytes (blood type A) from a healthy 23-year-old man were
prepared before the experiment. The blood was centrifuged (800 3 g, 10
min) and washed three times with PBS to remove the plasma and buffy coat.
After resuspension with PBS containing calcein (2 mM), the cells (6.33 105
cells/mL) were applied onto a poly-D-lysine-coated, glass-bottomed 35-mm
dish. After 2 h, small aliquots of peptides (10 mL) were added directly into
the dish at a ﬁnal concentration of 10 mM (9.8 mM MG and 0.2 mM
TAMRA-MG), and observed using CLSM.
RESULTS
Permeabilization of bacterial membranes by MG
Pores formed by MG in membranes of B. megaterium were
visualized using the inﬂux of soluble ﬂuorescent markers of
various sizes (Fig. 1). In the absence of peptide, calcein (di-
ameter, ;1 nm) did not permeate into the cytosol (Fig. 1 A).
Aliquots of MG solution, doped with a small amount of
TAMRA-MG (2%), were added into the dish at a ﬁnal peptide
concentration of 10 mM, which was larger than the minimal
inhibitory concentration under the same conditions (2.5mM).
The MG bound to bacteria, induced the inﬂux of calcein
(MW, 623; diameter,;1 nm) into the cytosol within seconds,
and internalized simultaneously (Fig. 1B,Movie S1).We also
used larger ﬂuorescent molecules to estimate pore size. The
4-kDa FITC-dextran entered the cytosol less efﬁciently than
calcein (Fig. 1 C). Cells were still distinguishable from the
background even after the addition of peptide. The rate of
inﬂux, calculated as based on FI, was ;60% (Fig. 1 F).
Therefore, the average size of poreswas estimated at;2.8 nm.
The possibility that 4-kDa FITC-dextran could not pass
through the peptidoglycan layers was excluded, because the
proline-introduced MG analogue peptide A9P-MG (GIGK-
WLHSPKKFGKAFVGEIMNS) induced a rapid inﬂux of
4-kDa FITC-dextran (Fig. 1 E). The 20-kDa FITC-dextran
(diameter,;6.6 nm) did not permeate the cell membrane at all
(Fig. 1 D), suggesting that the pores are smaller than 6.6 nm.
When the cell membrane was permeabilized with the deter-
gent Triton X-100, even 250-kDa FITC-dextran was inter-
nalized (Fig. 1 G).
Permeabilization of mammalian membranes
by MG
The permeabilization of plasma membranes of CHO-K1 cells
by MG was also examined, based on the inﬂux of ﬂuorescent
molecules (Fig. 2). Before the addition of peptide, calceinwas
FIGURE 1 Permeabilization of membranes by MG in B. megaterium.
Cells in calcein solution before (A) and 68–70 s after (B) addition of MG/
TAMRA-MG at a ﬁnal concentration of 10 mM (9.8/0.2 mM). Cells in 4.4-
kDa FITC-dextran solution (C) and 20-kDa FITC-dextran solution (D) 68–
70 s after addition of MG/TAMRA-MG at a ﬁnal concentration of 10 mM
(9.8/0.2 mM). (E) Cells in 4.4-kDa FITC-dextran solution 68–70 s after
addition of A9P-MG/TAMRA-A9P-MG at a ﬁnal concentration of 10 mM
(9.8/0.2 mM). From left to right: Calcein/FITC, TAMRA, differential
interference contrast (DIC), and merged images. All images were taken at
a magniﬁcation of 633 at 25C. (F) Percentages of inﬂux of ﬂuorescent
markers 3 min after addition of MG/TAMRA-MG (9.8/0.2 mM) are plotted
as a function of molecular mass of the marker. (G) Cells in 250-kDa FITC-
dextran solution after addition of Triton X-100 at a ﬁnal concentration of
0.4 w/v %.
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excluded from the cells (Fig. 2 A). The MG doped with 2%
TAMRA-MG also induced the inﬂux of calcein through
mammalian membranes (Fig. 2 B, Movie S2). The MG in-
duced membrane budding during the process of membrane
permeabilization (Fig. 2 B, arrow). In contrast to bacteria,
;70% of 20–70-kDa FITC-dextrans and even 30% of 250-
kDa FITC-dextran (diameter, ;23 nm) entered the cytosol
through the deformed membranes (Fig. 2, C and D). The
peptide-unbound cells indicated by arrowheads in Fig. 2 C
were much more distinguishable from the background than
the MG-bound cells. The MG peptide itself also entered the
cytosol (Fig. 2, B and C, Movie S2). To determine the intra-
cellular localization of the peptide, cells labeled with the
mitochondria marker Mitotracker Green FM were treated
with the TAMRA-labeled peptide (Fig. 2 E). The peptide was
colocalized with the mitochondria marker. The TAMRA ﬂuo-
rescence was also observed in nuclei. Thus, the internalized
peptide mainly accumulated in mitochondria and nuclei.
Effects of GAGs and ATP depletion on
membrane-permeabilizing activity of MG
The effects of negatively charged extracellular matrix com-
ponents on the membrane-permeabilizing activity of MG in
mammalian cells were estimated using calcein-entrapped
CHO-K1 cells and mutant cells. The CHO pgsD-677 lacks
FIGURE 2 Permeabilization of membranes by MG in
CHO-K1 cells. Cells (105 cells/mL, 633) in calcein solu-
tion before (A) and 68–70 s after (B) addition of MG/
TAMRA-MG at a ﬁnal concentration of 10 mM (9.8/0.2
mM). (B) Arrow indicates membrane budding. (C) Cells in
250-kDa FITC-dextran solution 68–70 s after addition of
MG/TAMRA-MG at same concentration. Image was mag-
niﬁed 3.53 from 203. Arrowheads indicate peptide-un-
bound cells. From left to right: Calcein/FITC, TAMRA,
DIC, and merged images. All images were taken at 25C.
(D) Percentages of inﬂux of ﬂuorescent markers 5 min after
addition of MG/TAMRA-MG (9.8/0.2 mM). (E) Cells with
MitoTracker Green FM staining 70 s after addition of MG/
TAMRA-MG at a ﬁnal concentration of 10 mM (9.8/0.2
mM). From left to right: MitoTracker, TAMRA, DIC, and
merged images.
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the negatively charged glycosaminoglycan heparan sulfate,
which was suggested to be important for the internalization of
cell-penetrating peptides (20). The CHO pgsA-745 lacks all
GAGs. The MG induced almost the same extent of calcein
leakage in CHO-K1 cells and its mutants (Fig. 3 A), indi-
cating that GAGs are not involved in permeabilization by
MG.
The effects of depletion of ATP on the leakage activity of
MG were also examined (Fig. 3 B). A combination of anti-
mycin A and DG was used to deplete ATP. The activity of
MG was not inﬂuenced by ATP depletion (Fig. 3 B), sug-
gesting that MG permeabilized the membranes via an ATP-
independent mechanism.
Lipid ﬂip-ﬂop induced by MG in
mammalian membranes
We investigated whether MG induces lipid ﬂip-ﬂop in living
mammalian membranes, based on the exposure of PS to the
cell surface (Fig. 4). The PS is a convenient probe for de-
tecting ﬂip-ﬂop because the lipid normally exists in the inner
leaﬂet of mammalian cell membranes (21). The PS was de-
tected using AV, which selectively binds to it over a certain
range of calcium concentrations (18). As described above,
the membrane deformation was great enough to permit;35-
kDa AV into the cytosol to recognize PS in the inner leaﬂet.
The cells were washed three times to recover the barrier
function of membranes after a 15-min incubation with the
peptide. To conﬁrm the membrane-impermeability of AV,
the sample was costained with Alexa 647-labeled CA of a
smaller molecular mass (;30 kDa). Many cells still permit-
ted the entry of CA (data not shown). However, the binding
of AV to the cell membrane was observed in CA-imperme-
able and MG-bound cells (Fig. 4, A and B), indicating that
MG induced lipid ﬂip-ﬂop in the living mammalian cell.
DISCUSSION
Studies using model membranes proposed several mechanisms
to explain the AMP-induced permeabilization of membranes.
In the toroidal pore model, suggested for magainin (7,8) and
other peptides (22–26), several peptides with surrounding
lipid molecules insert into the membrane to form a pore with
a deﬁned size, inducing mutually coupled leakage and lipid
ﬂip-ﬂop at relatively low peptide/lipid ratios (,1:100). With
the carpet mechanism, large amounts of peptides cover
membranes like carpets, and eventually disrupt membranes
like detergents (27). It should be noted that this mechanism
depends not only on peptide species but also on lipid com-
position. For example, if PS or phosphatidylethanolamine is
incorporated into a membrane, magainin disrupts the mem-
brane via a carpet-like mechanism (28). Neutralization of the
PS headgroup by positive charges of peptides tends to induce
a hexagonal II phase (29). The negative curvature induced by
neutralization or by incorporation of phosphatidylethanol-
amine inhibits the formation of toroidal pores requiring a
positive curvature of membranes (7,8), allowing peptides to
accumulate on the membrane.
Detailed information on the interaction of AMPs with
living cells has been lacking, although several studies used
ﬁxed cells (9–12,15–17). Mangoni et al. conﬁrmed the inﬂux
of FITC into the cytosol of unﬁxed Escherichia coli induced
by temporin L (30). However, permeability was tested 60min
after the addition of the peptide. There was no information on
the process of permeabilization, pore size, or peptide trans-
location. We characterized the process by which MG per-
meabilized unﬁxed biomembranes in detail.
We used Gram-positive B. megaterium as bacterial cells.
The absence of outer membranes makes the interpretation of
results straightforward. Furthermore, the strain is large, and
therefore convenient for microscopic observation, as evi-
denced in a recent study of nisin (31). Inﬂux experiments
were previously conducted using E. coli (30) and giant ves-
icles (31). However, pore size was not evaluated. We found
that the average diameter of pores formed by MG in the
plasma membrane of B. megaterium mainly containing
negatively charged lipid phosphatidylglycerol (32) was;2.8
nm, and certainly smaller than 6.6 nm (Fig. 1 F). The esti-
mated pore size was comparable to that determined in
phosphatidylglycerol-containingmodel membranes.Magainin
FIGURE 3 Effects of GAGs and ATP depletion
on membrane-permeabilizing activity of MG. (A)
Effects of GAGs. Calcein-entrapped cells (wild-type
K1, GAG-lacking pgsA-745, and heparan-sulfate-
lacking pgsD-677) were treated with 10 mM MG or
buffer for 1 h at 37C. The percentage of calcein
content relative to peptide-untreated cells is shown
(mean 6 SE, n ¼ 8). There was no signiﬁcance (p .
0.1). Data are representative of two independent
experiments. (B) Effects of ATP depletion. Calcein-
entrapped CHO-K1 cells were pretreated with a
combination of 50 nM antimycin A and 50 mM
DG or vehicle for 30 min, followed by 1-h incuba-
tion with 10 mM MG or vehicle in the presence or
absence of inhibitors at 37C. Percentages of calcein content are shown (mean 6 SE, n ¼ 10). Values were normalized to both peptide-free and
inhibitor-free cells. Data are representative of two independent experiments.
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2 was proposed to form a toroidal pore with a diameter of
2–3 nm and ;3.7 nm in a ﬂuorescence-based study (33)
and a neutron scattering-based study (34), respectively.
These observations suggest that MG permeabilizes bacterial
membranes by forming toroidal pores. The detergent-like
mechanism can be excluded, because the pores have a ﬁnite
size. The detergent Triton X-100 allowed the entry of large
250-kDa FITC-dextran (Fig. 1 G). One characteristic of the
toroidal pore is the induction of lipid ﬂip-ﬂop (7). However,
lipids rapidly move across bilayers via ﬂippases in the
membranes of B. megaterium (35). Therefore, it is essentially
impossible to discriminate peptide-induced from ﬂippase-
induced lipid ﬂip-ﬂop. Similar conclusions were drawn for a
chimeric peptide of cecropin and melittin, CM15 (36).
The permeabilization of membranes by MG was also ob-
served in mammalian cells (Fig. 2). However, the mode of
action was very different from that in bacterial membranes
(Fig. 1). The permeabilization was accompanied by exten-
sive deformation, including membrane budding (Fig. 2 B,
Movie S2). Large molecules such as 250-kDa FITC-dextran
(diameter, ;23 nm (37)) entered cells via deformed mem-
branes (Fig. 2 C). Magainin 2 is reported to release lactate
dehydrogenase (MW, 140 kDa; diameter, ;8 nm) from
mammalian cells (38,39). The human AMP LL-37 also re-
leases this enzyme from mammalian cells (12) and 40-kDa
proteins from Candida albicans (40), suggesting that AMPs
can cause massive disruption of membranes. However, the
size of lesions depends on the peptide species, because his-
tatin 5, an AMP derived from humans, released ATP but not
proteins from C. albicans (40). The sizes of lesions generated
by other AMPs in erythrocytes were estimated according to
the osmoprotection method: ;3.0 nm for indolicidin (41),
and 3.6–4.0 nm for temporin L (42). Further studies are re-
quired to understand what determines the size of pores pro-
duced by AMPs.
In the membrane-permeabilizing process of MG (Fig. 2,
Movie S2), it is possible that the formation of toroidal pores
was inhibited by some positive curvature-counteracting fac-
FIGURE 4 Lipid ﬂip-ﬂop induced by MG. CHO-K1
cells were incubated with MG/TAMRA-MG at a ﬁnal
concentration of 10 mM (9.8/0.2 mM) for 15 min, and
washed three times to close pores. Cells were stained by
FITC-AV and Alexa 647-labeled CA. The image was taken
at 25C. Lipid ﬂip-ﬂop was evident in the encircled cell.
(A, B) Two different ﬁelds of view are shown.
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tors, and peptides accumulated on the membrane to disrupt it,
similar to the carpet mechanism (27). We suspected choles-
terol and sphingomyelin to be such factors because of their
tendency to rigidify membranes. Indeed, the incorporation
of these lipids inhibits pore formation in PS-basedmembranes
(43). If cholesterol acts to inhibit the formation of pores, its
depletion would decrease the size of lesions. However, 250-
kDaFITC-dextran entered cholesterol-depleted cells similarly
to untreated cells (data not shown). The PS and phosphati-
dylethanolamine with negative-curvature tendency, mainly
in the inner leaﬂet of cell membranes, could inhibit pore
formation when they are exposed to the outer leaﬂet by
MG-induced lipid ﬂip-ﬂop (Fig. 4).
In contrast to its effect on CHO-K1 cells, MG achieves
;50% hemolysis in erythrocytes only at a much higher
concentration, i.e., 1 mM (44). However, a large difference in
susceptibility is apparent. In this study, 10 mM of MG were
added to 13 105 cells/mL, whereas 1mMwas added to 1.23
108 cells/mL in the hemolysis assay. Given the radius of the
cells, i.e., 10mm for CHO cells and 4mm for erythrocytes, we
calculated the membrane (monolayer) surface area/peptide
values to be 1.33 1010mm2/mmol and 2.43 1010mm2/mmol,
respectively. The two values are comparable, indicating the
membrane-permeabilizing activity of MG to be similar, be-
cause the lipid composition of erythrocytes (45) and CHO
cells (46) is not very different. We found that 10 mM of MG
were enough to lyse human erythrocytes completely at a lower
cell density of 6.33 105 cells/mL, corresponding to a surface
area/peptide ratio of 1.3 3 1010 mm2/mmol (Fig. 5).
We examined the effects of GAGs on the membrane-per-
meabilizing activity of MG (Fig. 3 A). The GAGs are known
to play a very important role in the interaction between cat-
ionic cell-penetrating peptides and cells (20). Similarities and
differences between these peptides and AMPs were dis-
cussed in a recent review (47). The effects of GAGs on the
permeabilization of membranes by MG were almost negli-
gible (Fig. 3 A). Magainin 2 was reported not to bind to
heparan sulfate (48). In contrast, LL-37 interacts with GAGs
(49). Energy depletion did not inﬂuence the membrane-per-
meabilizing activity of MG (Fig. 3 B), suggesting that MG
permeabilized membranes via direct physicochemical pep-
tide-lipid interaction.
Lipid ﬂip-ﬂop induced by MG was observed in CHO-K1
cells (Fig. 4). We used a calcium-containing buffer because
FIGURE 5 Hemolysis by MG. Erythrocytes in calcein
solution before (A) and 70 s after (B) addition of PBS
(control). Erythrocytes in calcein solution before (C), and
20 s (D) or 40 s (E) after addition of MG/TAMRA-MG at a
ﬁnal concentration of 10 mM (9.8/0.2 mM). All images
were taken at 25C and magniﬁed 33 from 203. Cell
concentration was 6.3 3 105 cells/mL.
Magainin-Living Cell Interactions 5763
Biophysical Journal 95(12) 5757–5765
AV binds to PS at certain concentrations of calcium (18).
Calcium was suggested to induce PS ﬂip-ﬂop by changing
the activities of aminophospholipid translocase and phos-
pholipid scramblase (50). Wurth and Zweifach showed,
however, that an inﬂux of calcium per se was not sufﬁcient to
stimulate PS ﬂip-ﬂop (51). Although the exposure of PS is a
hallmark of apoptotic cells, the possibility that MG induced
PS ﬂip-ﬂop via the apoptotic pathway can be excluded, be-
cause PS ﬂip-ﬂop in apoptotic cells requires several hours
(52).
The MG was internalized into the cytosol of B. megaterium
(Fig. 1) and CHO-K1 cells (Fig. 2). There are two pathways
of internalization: the translocation of pore-constituting pep-
tides upon the disintegration of toroidal pores, as proposed in
a liposomal study (7), and the entry of free peptides into the
cell through water-ﬁlled pores that are larger than the peptide
molecule. The internalization of MG into E. coli was previ-
ously demonstrated using electron microscopy (53). How-
ever, there was no information in that study on the timescale
of internalization. Other peptides were also conﬁrmed to be
internalized into the cytosol of bacterial (15,17) and mam-
malian (9–12,16) cells. However, the possibility that the
ﬁxation changed the distribution of peptides cannot be ex-
cluded (14).
Our previous report showed that MG translocated into the
cytosol of HeLa and TM12 cells (9). The translocation was
slightly affected by low temperature and sodium azide (9).
The inhibitory effect of low temperature is ascribable to an
increase in the rigidity of membranes. Membrane-per-
meabilizing activity was not inﬂuenced by ATP depletion
with the combination of antimycin A and DG (Fig. 3 B).
However, the translocation of MG was reduced by the ATP-
depleting agent sodium azide (9). The differences in cell lines
and the increased ionic strength using sodium azide might
affect the membrane-permeabilizing activity of MG. In ad-
dition, the membrane-rigidifying effects of azide, as reported
in human bladder carcinoma endothelial cells (54), could also
lower the activity of MG, similar to the effects of low tem-
perature. Indeed, ATP-depletion by sodium azide diminished
the membrane-permeabilizing activity of histatin 5 against
C. albicans by rigidifying membranes via an ATP-depletion-
driven polymerization of actin (55).
In this study, the dynamic interaction of MG with living
bacterial and mammalian cells was investigated in detail. The
peptide appeared to permeabilize cell membranes differently,
i.e., by a toroidal mechanism in the former cells, and by the
carpet mechanism against the latter. This information adds a
valuable contribution to the understanding of AMP-mem-
brane interactions and to the development of effective pep-
tidic antibiotics.
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